Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
M.D. Anderson Cancer Center
Thomas Jefferson University
Tempus AI
Sanofi
Washington University School of Medicine
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
NRG Oncology
M.D. Anderson Cancer Center
NextCure, Inc.
Black Diamond Therapeutics, Inc.
Elevation Oncology
NantCell, Inc.
Washington University School of Medicine
Cambridge University Hospitals NHS Foundation Trust
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Fred Hutchinson Cancer Center
West Virginia University
Incyte Corporation
Stanford University
Centre Hospitalier Universitaire Vaudois
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Lumos Pharma
Pfizer
Tetra Bio-Pharma
InSightec
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Yale University
CureOne
National Institutes of Health Clinical Center (CC)
Helsinn Healthcare SA
Pfizer
University of Pittsburgh
Cota Inc.
AIO-Studien-gGmbH
University of California, Davis
Masonic Cancer Center, University of Minnesota
Cornerstone Pharmaceuticals
Jonsson Comprehensive Cancer Center
Virginia Commonwealth University
Merck Sharp & Dohme LLC